# EDGAR Filing Document

**Accession Number:** 0001787518
**File Stem:** 0001213900-25-098218
**Filing Date:** 2025-10
**Character Count:** 7438
**Document Hash:** 36499a096ab8799557043ab3e088960b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-098218.hdr.sgml**: 20251010

**ACCESSION NUMBER**: 0001213900-25-098218

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251008

**FILED AS OF DATE**: 20251010

**DATE AS OF CHANGE**: 20251010

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Kotaieva Anastasiia
- **CENTRAL INDEX KEY:** 0002045096

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39341
- **FILM NUMBER:** 251388977

**MAIL ADDRESS:**
- **STREET 1:** MEDINAT HA-YEHUDIM 2
- **CITY:** HERTZLIYA
- **STATE:** L3
- **ZIP:** 4676602
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nukkleus Inc.
- **CENTRAL INDEX KEY:** 0001787518
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 383912845
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 575 FIFTH AVENUE, 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-791-4663

**MAIL ADDRESS:**
- **STREET 1:** 575 FIFTH AVENUE, 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Brilliant Acquisition Corp
- **DATE OF NAME CHANGE:** 20190909

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Kotaieva Anastasiia<br><sub>(Last) (First) (Middle)</sub><br>C/O NUKKLEUS INC.,<br>575 FIFTH AVENUE, 14TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10017<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Nukkleus Inc. [ NUKK ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, $0.0001 par value per share | 2025-10-08 |  | P |  | 117568 | A | <sup>(1)</sup> | 587520 | I | See Footnote<sup>(1)</sup> |
| Common Stock, $0.0001 par value per share | 2025-10-09 |  | P |  | 259864 | A | <sup>(2)</sup> | 847384 | I | See Footnote<sup>(2)</sup> |
| Common Stock, $0.0001 par value per share | 2025-10-09 |  | P |  | 999989 | A | <sup>(3)</sup> | 1847373 | I | See Footnote<sup>(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Warrant | $0.0001 | 2025-10-07 |  | P |  | 1000000 |  | 2025-10-07 | 2030-08-11 | Common | 1000000 | $0.0001 | 1501424 | I | See Footnote 3 |
| Warrant | $2.00 | 2025-10-08 |  | X |  |  | 150000 | 2024-06-11 | 2029-06-11 | Common | 150000 | <sup>(1)</sup> | 1351424 | I | See Footnote 1 |
| Warrant | $2.41 | 2025-10-09 |  | X |  |  | 351424 | 2024-11-08 | 2029-11-08 | Common | 351424 | <sup>(2)</sup> | 1000000 | I | See Footnote 2 |
| Warrant | $0.0001 | 2025-10-09 |  | X |  |  | 1000000 | 2025-08-11 | 2030-08-11 | Common | 1000000 | <sup>(3)</sup> | 0 | I | See Footnote 3 |

---

### Footnotes:

(1) Shares issued upon exercise (on a cashless basis) of a warrant issued in June 2024 to X Group Family of Funds Limited Partnership for 150,000 shares (after giving effect to a reverse split implemented in October 2024). Anastasiia Kotaieva, a director of the Company, is the owner of X Group Family of Funds Limited Partnership.

(2) Shares issued upon exercise (on a cashless basis) of a warrant issued in November 2024 to X Group Family of Funds Limited Partnership for 351,424 shares. Anastasiia Kotaieva, a director of the Company, is the owner of X Group Family of Funds Limited Partnership.

(3) Shares issued upon exercise (on a cashless basis) of a pre-funded warrant issued in August 2025 to an unrelated third party for a total of 1,702,088 shares and assigned on October 7, 2025 to X Group Family of Funds Limited Partnership. Anastasiia Kotaieva, a director of the Company, is the owner of X Group Family of Funds Limited Partnership.

**Signature:** /s/ Anastasiia Kotaieva  
**Date:** 2025-10-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**